Evidence map›Paper›PMID 42394833›Full record

ArticleStigma and health2026

"Stigma's Every Day, All Day Long": A Qualitative Exploration of Experiences of Overlapping Stigmas and HIV Prevention Service Use Among Women Who Use Drugs.

Stephanie A Meyers-Pantele, Ingrid Yu, Keith J Horvath, Lisa Eaton, Stefan Baral, Laramie R Smith, Jamila K Stockman

Abstract read
In one paragraph

Article in Stigma and health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Stephanie A Meyers-PanteleDivision of Infectious Diseases and Global Public Health, University of California, San Diego.ORCID 0000-0002-8564-0183
Ingrid YuDepartment of Psychology, San Diego State University.
Keith J HorvathDepartment of Psychology, San Diego State University.
Lisa EatonDepartment of Human Development and Family Sciences, University of Connecticut.
Stefan BaralDivision of Infectious Disease Epidemiology, Johns Hopkins University.
Laramie R SmithDivision of Infectious Diseases and Global Public Health, University of California, San Diego.
Jamila K StockmanDivision of Infectious Diseases and Global Public Health, University of California, San Diego.

Funding

VirologyP30AI036214 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SONIA JAIN · 1994 to 2026
$78.4M
LOTUS: An mHealth Intervention to Improve HIV Prevention Service Engagement and Intersectional Stigma among Racially Diverse Women Who Use DrugsK01DA055983 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Stephanie Alice Meyers-Pantele · 2022 to 2026
$941k
NIAID NIH HHS P30 AI036214NIDA NIH HHS K01 DA055983
6 · The paper itself

Abstract

In 2025, gendered inequities in HIV risk and harm remain for women who use drugs (WWUD). WWUD also have low levels of HIV prevention service engagement and likely experience intersectional stigma. The present study sought to explore WWUD's experiences with intersectional stigma and how those experiences shape HIV prevention service use to better inform the development of tailored intervention efforts. Individual in-depth interviews were conducted within the mHeaLth interventiOn To redUce Stigma study, a study to develop and pilot test an intervention to reduce intersectional stigma and improve HIV prevention service engagement among racially and ethnically diverse WWUD. Interviews elicited participants' experiences with stigma and perceived barriers and facilitators to HIV prevention services. Data were analyzed via thematic analysis. Intersectionality theory and the Health Stigma and Discrimination Framework were applied to emergent themes to conceptualize study findings. Narratives from 26 WWUD in San Diego County highlighted ubiquitous homelessness, drug use, misogyny, and/or other intersectional stigmas that were driven by structural-level factors (e.g., criminal justice environment, housing systems, local politics) and resulted in violence, health care avoidance, and receiving poor-quality care. Though most women reported not experiencing stigma within HIV prevention services, many still reported barriers to care (i.e., time, transportation, HIV stigma, shame/embarrassment, and lack of trustworthy information). Collectively, these findings highlight the pervasive nature of intersectional stigma in WWUD's lives, the detrimental impact that stigma has (i.e., violence and poor-quality care), and the need for flexible, mobile, and tailored HIV prevention interventions that target intersectional stigma.

Indexed as

discriminationgenderHIV testingintersectionalitysubstance use

Identifiers

PMID42394833
PMCPMC13327734

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.